Thomas Reynolds
Direttore/Membro del Consiglio presso MEI PHARMA, INC.
Patrimonio netto: 1 455 $ in data 30/06/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| David Urso | M | 60 | 10 anni | |
| Charles Baltic | M | 63 | 13 anni | |
| Justin File | M | 53 | 1 anni | |
| Fred Driscoll | M | 73 | 6 anni | |
| Nick Glover | M | 55 | 11 anni | |
| David Walsey | M | - | 6 anni | |
| Eugene Park | M | - | 3 anni | |
| Caroline Ruiz | F | - | 2 anni | |
| Eric Deng | M | - | 3 anni | |
| Jason Sausser | M | - | 2 anni | |
| Kathleen Large | F | 64 | 5 anni | |
| Taheer Mehboob Datoo | M | 33 | 1 anni | |
| Steven Wood | M | 41 | 1 anni | |
| Anne Frese | F | - | 2 anni | |
| Richard Ghalie | M | 66 | 8 anni | |
| Natasha Hernday | F | 52 | 13 anni | |
| James Flynn | M | 43 | 1 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Niclas Stiernholm | M | - | 8 anni | |
| Douglas Williams | M | 66 |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | 6 anni |
| Vaughn Himes | M | 63 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | 18 anni |
| Robert L. Kirkman | M | 75 | 8 anni | |
| Brian Drazba | M | 63 | 6 anni | |
| Thomas M. Zech | M | 72 | 7 anni | |
| Christine Anna White | M | 72 | 13 anni | |
| Calvin Stiller | M | 83 | 8 anni | |
| Daniel Gold | M | 70 | 13 anni | |
| Jan Skvarka | M | 57 | 2 anni | |
| Helena Tayton-Martin | M | 57 | 4 anni | |
| Larry K. Benedict | M | 63 | 8 anni | |
| Luke Beshar | M | 65 | 7 anni | |
| Leah Cann | F | 63 | 7 anni | |
| Paul Walker | M | 49 | 1 anni | |
| Pete de Spain | M | - | 7 anni | |
| Darren Cline | M | 59 | 9 anni | |
| Charles Romp | M | - | 13 anni | |
| R. Dean Peterson | M | - | 4 anni | |
| Christopher Boerner | M | 53 | 5 anni | |
| Nancy Simonian | M | 63 | 11 anni | |
| Ofir Moreno | M | - | 12 anni | |
| James Kyle Bryan | M | - | - | |
| Eric Sievers | M | 60 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | 7 anni |
| Scott Myers | M | 57 | - | |
| Sujay Kango | M | 60 | 2 anni | |
| Paolo Pucci | M | 63 | 1 anni | |
| James DeMesa | M | 66 | 9 anni | |
| John McLaughlin | M | 72 | 9 anni | |
| Tamar Howson | F | 75 | 4 anni | |
| Michael G. Moore | M | - | 7 anni | |
| Kevan E. Clemens | M | 80 | 7 anni | |
| Rosemary Harrison | M | 41 | 1 anni | |
| Cheryl Cohen | F | 58 | 2 anni | |
| Michael Kamarck | M | 73 | 1 anni | |
| Abdelmalik Slassi | M | 62 | 3 anni | |
| Tina Beamon | F | - | 2 anni | |
| Tina Albertson | M | 51 | 5 anni | |
| Kelly Powell | F | - | - | |
| Ingmar Bruns | M | 49 | 1 anni | |
| Gabriel Luciano | M | - | 3 anni | |
| Alejandro Ricart | M | - | 1 anni | |
| Jamie A. Tereschuck | F | - | - | |
| Jan Hillson | M | 71 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | 6 anni |
| Brian Jahns | M | - | - | |
| Benjamin Looker | M | 42 | - | |
| Chao Hong Hu | M | 58 | 6 anni | |
| Sarah Aebersold | F | 48 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | 5 anni |
| Yaping Shou | M | - | 2 anni | |
| Igor Gorbatchevsky | M | - | 2 anni | |
| Naomi Hunder | M | 54 | 7 anni | |
| Neil Josephson | M | - | 6 anni | |
| Brian Powl | M | 50 | - | |
| Charles Sang | M | 56 | 2 anni | |
| Todd Butler | M | - | 2 anni | |
| Robert S. Whitehead | M | 74 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | 2 anni |
| Samuel Yonren | M | - | - | |
| Wendy J. Levin | M | - | - | |
| Morris Z. Rosenberg | M | 64 | 8 anni | |
| James A. Harper | M | 77 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | 6 anni |
| Michael McDonald | M | - | 4 anni | |
| Michael J. Dwyer | M | 68 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | 3 anni |
| Eleanor Ramos | M | 67 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | - |
| Dennis M. Miller | M | 61 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | - |
| David Hopper MacCallum | M | 86 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | 5 anni |
| George B. Rathmann | M | - |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | - |
| Nicole Onetto | M | 71 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | 4 anni |
| Daniel F. Hoth | M | 78 | 4 anni | |
| Judith Ann Hemberger | M | 77 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | 3 anni |
| Paul J. Carter | M | - | 5 anni | |
| Robert D. Mass | M | 70 | 11 anni | |
| Christopher Pawlowicz | M | - | - | |
| Pamela A. Trail | M | 68 | 1 anni | |
| Elaine Waller | M | 72 | 10 anni | |
| Jorge Cerda Lucero | M | - | - | |
| Craig A. Halverson | M | - |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | 3 anni |
| Diana Hausman | M | 61 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | 4 anni |
| Scott Robert Peterson | M | 62 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | 2 anni |
| Patrick L. Bobbitt | M | - | 1 anni | |
| Bruce J. Seeley | M | 59 | 3 anni | |
| Karen Potts | M | 61 | - | |
| Benjamin Cadieux | M | - | 1 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 79 | 79.80% |
| Canada | 21 | 21.21% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Thomas Reynolds
- Contatti personali
